Tango Therapeutics Inc. (TNGX)
undefined
undefined%
At close: undefined
3.06
-0.16%
After-hours Dec 13, 2024, 04:15 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue 36.53M 24.86M 37.04M 7.66M 24.65M
Cost of Revenue 115.20M 4.03M 1.97M 1.63M 32.27M
Gross Profit -78.67M 20.83M 35.08M 6.03M -7.63M
Operating Income -114.17M -111.07M -58.19M -52.20M -15.16M
Interest Income 6.62M 1.46M 495.00K 108.00K 684.00K
Pretax Income -101.61M -108.12M -57.94M -51.97M -14.10M
Net Income -101.74M -108.18M -58.23M -51.86M -14.10M
Selling & General & Admin 35.50M 30.02M 17.60M 9.87M 7.54M
Research & Development 115.20M 105.91M 77.64M 49.99M 32.27M
Other Expenses - 2.95M 247.00K 120.00K -
Operating Expenses 150.70M 135.93M 95.23M 59.86M 7.15M
Interest Expense - - - - -
Selling & Marketing Expenses - - - - -
Cost & Expenses 150.70M 135.93M 95.23M 59.86M 39.43M
Income Tax 134.00K 54.00K 292.00K -108.00K -
Shares Outstanding (Basic) 94.57M 87.82M 62.11M 31.93M 8.99M
Shares Outstanding (Diluted) 94.57M 87.82M 62.11M 31.93M 8.99M
EPS (Basic) -1.08 -1.23 -0.94 -1.62 -1.57
EPS (Diluted) -1.08 -1.23 -0.94 -1.62 -1.57
EBITDA -111.76M -109.46M -57.29M -51.48M -14.52M
Depreciation & Amortization 2.42M 4.03M 1.97M 1.63M 643.00K